{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-019553","form_type":"8-K","ticker":"RBOT","cik":"0001812173","company_name":"Vicarious Surgical Inc.","filed_at":"2024-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.635415+00:00","generated_at":"2026-06-05T04:51:03.874095+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Vicarious Surgical Q4 2023 GAAP net loss $13.1M; 2024 cash burn guided ~$50M","bullets":["Q4 2023 GAAP net loss $13.1M ($0.06/sh); adjusted net loss $14.6M ($0.07/sh), improving from $19.9M ($0.16/sh) in Q4 2022.","Full year 2023 GAAP net loss $71.1M ($0.49/sh); adj net loss $76.3M ($0.52/sh); cash burn $63.4M met objective.","Cash and investments $98.2M at year-end; 2024 cash burn guidance narrowed to ~$50M.","Signed fourth major hospital partnership with Intermountain Health; total partner hospitals exceed 250.","V1.0 system on track for spring cadaveric testing; integration expected fall 2024; appointed Randy Clark President."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-019553","json":"https://secwatch.observer/filing/0001213900-24-019553.json","markdown":"https://secwatch.observer/filing/0001213900-24-019553.md","text":"https://secwatch.observer/filing/0001213900-24-019553.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1812173/000121390024019553/0001213900-24-019553-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1812173/000121390024019553/ea0201080-8k_vicarious.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T04:51:03.874095+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2b6d2e49040d3c58d529e2bed0d873f579d16c56","claim":"Vicarious Surgical Inc. reported fourth quarter and full year ended December 31, 2023 results: net income GAAP net loss for the fourth quarter was $13.1 million, equating to a net loss per share of $0.06, as compared to a GAAP, EPS GAAP net loss for the fourth quarter was $13.1 million, equating to a net loss per share of $0.06, as compared to a GAAP. Guidance reaffirmed.","evidence_excerpt":"On March 4, 2024, Vicarious Surgical Inc. (the “Company”) issued a press release announcing its results for the fourth quarter and full year ended December 31, 2023 and providing a business update.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390024019553/0001213900-24-019553-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter and full year ended December 31, 2023"},{"label":"Net income","value":"GAAP net loss for the fourth quarter was $13.1 million, equating to a net loss per share of $0.06, as compared to a GAAP"},{"label":"EPS","value":"GAAP net loss for the fourth quarter was $13.1 million, equating to a net loss per share of $0.06, as compared to a GAAP"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}